REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/15/2026
Back to search
Official data from USPTO
GUIDEPX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GUIDEPX
ST13
US500000079285049Class
5, 10, 44
Filing
79285049
Registration
6382768
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
06/16/2026
Trademark type
Word
Nice classes
5, 10, 44
Filing date
02/12/2020
Registration date
06/15/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/15/2021
Last transaction
06/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
11
Owner location
CA
Examiner
PODESTA, GIDETTE
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Qualisure Diagnostics Inc.
Representatives
Jessica Bromall Sparkman Jeffer Mangels Butler & Mitchell LLP
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Clinical diagnostic reagents for medical use; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; pharmaceutical preparations for in vivo diagnostic or therapeutic usei-vivo diagnostic agent used for detection and monitoring of tumors; drug test kits containing medical diagnostic reagents and assays for testing of body fluids
Class 10
Testing apparatus for medical purposesfor testing bloodtissue biopsiestumorscellscancer cellsDNARNAbiomarkers; apparatus for use in medical analysisapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; diagnostic apparatus for medical purposesdetecting tumors; medical diagnostic apparatus for testing bloodtissue biopsiestumorscellscancer cellsDNARNAincorporating recorded software using a machine learning algorithm to examine genomic information and identify biomarkers
Class 44
Medical diagnostic testingmonitoring and reporting services; medical testing for diagnostic or treatment purposes; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis
Publications
History of USPTO decisions and trademark events.
33 publications found
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
12/10/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
01/04/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/24/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/29/2021
FIMP
FINAL DISPOSITION PROCESSED
09/29/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/15/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/15/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/30/2021
PUBO
PUBLISHED FOR OPPOSITION
03/30/2021
GPNX
NOTIFICATION PROCESSED BY IB
03/28/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/10/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/10/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/23/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/23/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/23/2021
ALIE
ASSIGNED TO LIE
02/22/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/19/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/17/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/17/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/17/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/17/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/17/2020
RFNT
REFUSAL PROCESSED BY IB
06/19/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/30/2020
RFRR
REFUSAL PROCESSED BY MPU
05/29/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/12/2020
MAFR
APPLICATION FILING RECEIPT MAILED
05/12/2020
CNRT
NON-FINAL ACTION WRITTEN
05/11/2020
DOCK
ASSIGNED TO EXAMINER
05/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/08/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/07/2020
Continuous trademark protection
Get notified about every new filing that threatens GUIDEPX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.